Several studies have showed that chronic liver disease, including hepatic fibrosis, liver cirrhosis, alcoholic fatty liver and nonalcoholic fatty liver, all associated with the upregulation of endocannabinoids and their receptor, CB1 [2]–[10]. Here, CNR1 is linked to Hepatic fibrosis.